Table 1 Clinical characteristics of T2DM receiving intensive insulin pump therapy.
From: The relationship between different C-peptide level and insulin dose of insulin pump
Clinical features | Results (\(\overline x \pm s\)) |
|---|---|
Age (years) | 52.9 ± 11.9 |
Duration of disease (year) | 7.11 ± 6.78 |
Weight (Kg) | 72.56 ± 12.07 |
Waist circumference (cm) | 94.58 ± 11.53 |
Body mass index (kg/m2) | 25.30 ± 3.47 |
HbAlc (%) | 11.1 ± 1.8 |
Fasting blood glucose (mmol/L) | 10.51 ± 3.36 |
Blood glucose at 2-h after meal (mmol/L) | 20.52 ± 4.27 |
Fasting plasma C-peptide (ng/ml) | 1.25 ± 0.70 |
Postprandial 2hc peptide (ng/ml) | 2.65 ± 1.41 |
TG (mmol/L) | 2.59 ± 2.51 |
TC (mmol/L) | 4.51 ± 1.15 |
HDL-C (mmol/L) | 1.06 ± 0.13 |
LDL-C (mmol/L) | 2.98 ± 0.93 |
Average occurrence times of hypoglycemia (times/cases) | 0.04 ± 0.19 |
Mean blood glucose reaching standard time (day) | 3.94 ± 1.02 |
